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Redox-Active Cyclic Bis(cysteinyl)peptides
as Catalysts for In Vitro Oxidative Protein Folding
active-site sequence composition, as supported by muta-
genesis studies [21–26]. However, synthetic fragments re-
lated to the active sites of Trx, Grx, Trr, and PDI were all
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82152 Martinsried found to exhibit redox potentials in the rather narrow range
between 215 mV and 190 mV [27].Germany
In order to investigate whether the artificial constraints
imparted to synthetic active-site fragments of the oxido-
reductases could mimic those present in the enzymes,Summary
we synthesized sequences 10–15 of Grx (1), 31–36 of
Trx (2), 35–40 of PDI (3), and 134–139 of Trr (4) andThe active-site hexapeptides of glutaredoxin (Grx), thi-
oredoxin (Trx), protein disulfide isomerase (PDI), and subjected them to backbone cyclization (Figure 1). With
the exception of the Trr peptide 4, the Grx, Trx, and PDIthioredoxin-reductase (Trr) containing the common
motif Cys-Xaa-Yaa-Cys were conformationally re- peptides 1–3 were better oxidants than the related linear
fragments [27], and a strong correlation between redoxstricted by backbone cyclization, and their redox po-
tentials were found to increase in the rank order of potentials and catalytic effects on rate and efficiency of
RNase A refolding was observed, clearly supporting theTrr  Grx  Trx  PDI peptide, with E0 values ranging
between 204 mV and 130 mV. In each peptide the usefulness of these small peptides as folding adjuvants.
The results also suggest that the major foldase activitythiol pKa of one Cys residue was found to be lower
than the other (e.g., 7.3 against 9.6 in the PDI peptide). of PDI derives from its molecular-chaperone property.
Both the yield and rate of refolding of reduced RNase A
in the presence of the bis(cysteinyl)peptides increased Results
with the oxidizing character of the cyclic compounds.
These results show that small peptides can function as Synthesis of the Bicyclic Peptides 1–4
adjuvants for the in vitro oxidative folding of proteins. Based on the redox properties of synthetic linear octa-
peptides from the active sites of Grx, Trx, PDI, and Trr
Introduction [27], four new peptides were designed by shortening
the backbone length to six residues and by connecting
Folding of nascent cysteine-containing proteins with the N and C termini to reduce the conformational free-
concomitant formation of the correct disulfide connec- dom (Figure 1).
tivities is supported in vivo by a wide variety of molecular The linear hexapeptide precursors were synthesized
chaperones and folding catalysts. In the endoplasmic on the chlorotrityl resin with Fmoc/tBu chemistry and
reticulum (ER) of eukaryotes, PDI acts as a molecular cleaved in the side chain fully protected form. The N
chaperone [1–3] and mediates the formation and reshuf- and C termini were condensed with HBTU/HOBt/DIEA
fling of disulfides [4], although more recently other en- under low peptide concentration in order to favor the
zymes have been identified that are possibly involved intramolecular reaction. The S-tert-buthylthio (StBu)
in this process. Such enzymes include the ER oxidore- protecting groups of the Cys residues were selectively
ductin 1 protein (Ero1p) from S. cerevisiae [5, 6] and removed by reduction with phosphines [28], and the
the human counterpart Ero1-L [7]. In the periplasm of dithiol compounds were oxidized to the bicyclic form.
prokaryotes, the enzymes that catalyze the oxidation of The monocyclic Grx peptide was converted in high
nascent proteins belong to the Dsb (disulfide bond) fam- yields to the bicyclic compound 1 with di-tert-butyl-
ily [8]. azodicarboxylate in DMF [29], whereas this procedure
These enzymes and the other thiol/disulfide oxidore- failed with the monocyclic Trx peptide. The NMR confor-
ductases Trx [9] and Grx [10] share the common redox- mational analysis of this peptide in DMF revealed a well-
active motif Cys-Xaa-Yaa-Cys in an overall highly ho- defined planar conformation of the ring with the two
mologous 3D structure, the so-called Trx fold [11–15], thiols pointing outside into opposite directions, which
where the tetrapeptide is located at the N terminus of would well explain the unfavorable formation of the di-
an  helix. Also, Trr contains the same redox-active sulfide bond in the organic solvent.
sequence, but the overall structure of this enzyme differs Air oxidation of the monocyclic Trx, PDI, and Trr pep-
from the Trx fold [16]. Despite these homologies, the tides to the corresponding bicyclic compounds 2–4 was
enzymes are characterized by redox potentials ranging a slow process accompanied by formation of a minor
from the highly reducing value of 270 mV for Trx [17] fraction of oligomers.
to the oxidizing values determined for PDI (110 mV
[18], 175 mV [19], and 145 mV for the isolated N-ter-
Redox Potentials of the Bicyclic Peptides 1–4minal domain [20]) or DsbA (122 mV [21]). These differ-
The redox potentials were determined at pH 7 and 25Cent redox properties have mainly been attributed to the
by equilibration of the bicyclic peptides 1–4 with the
reference redox pairs GSH/GSSG and cysteine/cystine.1Correspondence: moroder@biochem.mpg.de
The oxidized and reduced forms of each reference redox2 Present address: 4SC AG, Am Klopferspitz 19, 82152 Martinsried,
Germany. pair were used in large excess over the peptides to allow
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Figure 1. Amino Acid Sequences of the Bicy-
clic Peptides 1–4
Circles indicate the active-site residues Cys-
Xaa-Yaa-Cys. The arrows indicate the CO→NH
amide bonds of the peptide backbone.
their concentrations at equilibrium to be considered un- pound 4 and the related linear octapeptide had almost
identical redox potentials, indicating either that back-changed. Multiple experiments were performed at differ-
ent GSH/GSSG or cysteine/cystine ratios. All the ex- bone cyclization in the latter case did not induce relevant
conformational features or that these could not signifi-pected redox species present at equilibrium ( i.e., the
reduced [Pred] and oxidized [Pox] cyclic peptides, the two cantly affect the redox property of the disulfide.
mixed mono-disulfide derivatives with glutathione
[P-SG] or cysteine [P-Cys], and the mixed bis-disulfide
derivatives with glutathione [P-(SG)2] or cysteine Thiol pKa Values of the Monocyclic Peptides
pH titration of the thiol groups was followed by measur-[P-Cys2], as shown in Figure 2 for compounds 1 and 2)
were identified by LC-ESI-MS. The product distribution ing the absorbance of the reduced peptides at 238 nm
(Figure 3). The pH-dependent absorbance of the Grxat equilibrium was then quantified by HPLC, as pre-
viously reported for the linear octapeptides [27]. When peptide was corrected by subtracting the contribution
of Tyr because the phenol group has a pKa of aboutcompound 2 or 3 was treated with glutathione, the domi-
nant component in the mixture was P-(SG)2, whereas 10 and its extinction coefficient at 238 nm increases
dramatically with the pH. For the Trx and PDI peptides,Pox could not be detected, suggesting that formation of
stable mixed disulfides was highly favored. The redox the contribution of Trp was taken into account, although
its absorbance at 238 nm is only slightly dependent onpotentials for these two peptides were therefore deter-
mined only by using the cysteine redox system as a pH. The titration curves of the Trx, PDI, and Trr peptides
were fitted to a double titration model [32], which al-reference. For compounds 1 and 4, both the glutathione
and cysteine reference systems were used, and within lowed extraction of the pKa values of 7.7 and 9.8 for the
Trx peptide, 7.3 and 9.6 for the PDI peptide, and 7.6the limits of experimental errors, identical redox poten-
tials were derived from the E0 values of 240 mV for and 10.0 for the Trr peptide (Table 1). The Grx peptide
was titrated only up to pH 9 to prevent complete ioniza-glutathione [30] and223 mV for cysteine [31]. Interest-
ingly, peptides 1 and 4 showed a lower tendency to tion of the Tyr side chain, and a pKa of 7.9 was derived
from fitting the experimental data points to a single titra-form mixed disulfide bonds with cysteine than with glu-
tathione. As listed in Table 1, the redox potentials of the tion model [32]. By this procedure the deprotonation of
the second thiol group was not experimentally ob-four bicyclic peptides range from 204 mV for the Trr
peptide 4 to 130 mV for the PDI peptide 3, with the served, but it is supposed to occur at pH 9.5–10, as for
the other peptides.Grx (1) and Trx (2) peptides showing the intermediate
E0 values of178 mV and152 mV, respectively. Com- These pKa values indicate that in the Cys-Xaa-Yaa-
Cys motif of the cyclic peptides the two Cys residuespounds 1–3 were found to be considerably more oxidiz-
ing than the related linear octapeptides, whereas com- are not equally strong nucleophiles and that one is even
Figure 2. HPLC Profiles of the Thiol/Disulfide
Exchange Reactions
(A) Compound 1 equilibrated with GSH/GSSG
(1:1) at pH 7 and 25C.
(B) Compound 2 equilibrated with cysteine/
cystine (8.9:1) at pH 7 and 25C.
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Table 1. Thiol pKa Kox and E0 Values of Compounds 1–4
Peptide Thiol pKa Kox [mM]b E0 [mV]c Kox [mM]b E0 [mV]d E0 [mV]e E0 [mV]
GSH/GSSG Cysteine/Cystine Octapeptide Enxyme
Grx (1) 7.9  0.1 n.d.a 9.4  0.4 179 33  7 178 215 233 [24]
Trx (2) 7.7  0.1 n.d. n.d. 4.2  0.2 152 190 270 [17]
9.8  0.1
PDI (3) 7.3  0.1 n.d. n.d. 0.8  0.2 130 205 110 [18]
9.6  0.1 145 [20]
175 [19]
Trr (4) 7.6  0.1 52  5 201 230  80 204 210 254/271 [39]
10.0  0.2
For comparison, the redox properties of the linear active-site octapeptides Grx-(10–17), Trx-[His37]-(31–38), PDI-(35–42), and Trr-(134–141) and
of the native enzymes are reported.
a Not determined.
b The Kox values were extrapolated from the hyperbolic fitting with Equation 2.
c E0 (GSH/GSSG)  240 mV [30].
d E0 (cysteine/cystine)  223 mV (adapted from reference [31]).
e See reference [27]
a much stronger acid than usually expected for this compounds 1–3 (Table 2 and Figure 5). Compound 4 was
not investigated for catalytic activity in protein refoldingamino acid (pKa  8.4).
because of its significantly more reducing character.For confirmation of the UV results, pH titration of the
Refolding experiments of RNase A with the correspondingthiol groups of the Trx and PDI peptides was followed
linear octapeptides have been reported previously [34].by NMR (Figure 4). From these experiments the pKa
Under optimal refolding conditions, about 81% activevalues of 7.6 and 7.4 were attributed to Trx-Cys32 and
enzyme was recovered after 23 hr. From a fitting of thePDI-Cys39, respectively. These values are in agreement
experimental curve with a first-order kinetic equation, awith those determined by UV.
maximal yield (Amax) of 83% was extrapolated, with an
initial refolding rate (vi) of 3.6 pmol/min. Upon addition
of catalytic amounts of peptide, e.g., at a GSH/GSSG/Refolding of Reduced and Denatured RNase A
Refolding of reduced and denatured RNase A was car- peptide molar ratio of 40:8:0.8, Amax and vi increased
with the increasing oxidizing properties of the peptides.ried out at 30C under optimal redox conditions (1 mM
GSH/0.2 mM GSSG) at a GSH/GSSG/protein molar ratio Accordingly, compound 1 led to 88% reactivation after
23 hr and to a 14% increment of vi, whereas compoundsof 40:8:1 [33], as well as under nonoptimal conditions
(0.5 mM GSH/0.1 mM GSSG) at a GSH/GSSG/protein 2 and 3 yielded 94% and 95% active RNase A, respec-
tively, with 25% and 39% faster initial rates.molar ratio of 20:4:1. Rates and yields of refolding were
then compared with those determined upon addition of Under nonoptimal glutathione buffer concentrations,
Figure 3. pH Titration of the Thiol Groups of
the Reduced Compounds 1–4 at 25C
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Figure 4. pH Dependence of the Chemical
Shifts of the 	CH2 Protons of the Cys Res-
idues
(A) Cys32 of the reduced compound 2.
(B) Cys39 of the reduced compound 3.
only 53% enzyme activity was recovered after 24 hr, Finally, the redox activities of the peptides were inves-
tigated in the absence of glutathione buffer and com-and Amax and vi were 64% and 1.1 pmol/min. The effects
of the cyclic peptides on the refolding were investigated pared to the redox property of GSSG at an oxidant/
protein ratio of 4:1. After 24 hr, 42% activity was recov-by replacement of half of the GSSG concentration with
each peptide. Compounds 1 and 2 provided a significant ered with GSSG, with an Amax of 53% and a vi of 0.9
pmol/min. In comparison, the peptides provided 72% uprecovery of activity (Amax about 80%), and the vi values
increased to 1.7 pmol/min and 2.2 pmol/min, respec- to 86% active RNase A within 24 hr, with a vi increment of
2.5 up to four times.tively. In the presence of compound 3, 83% active en-
zyme was recovered after 24 hr, and vi was enhanced
by a factor of 2.5. Discussion
These data confirm that both the efficacy and rate of
refolding were significantly improved with the increasing From findings of mutagenesis studies of T4 Trx [35], E.
coli Trx [22, 36], human PDI [23, 37], and E. coli DsbAoxidizing property of the cyclic peptides, with the PDI
peptide 3 being the best oxidant as well as the best [21, 26], there is a general consensus that the redox
properties of thiol/disulfide oxidoreductases are mainlyrefolding adjuvant. Although adding catalytic amounts
of the peptides to optimal GSH/GSSG concentrations dictated by the sequence composition of the common
Cys-Xaa-Yaa-Cys motif in the spatial framework of theirafforded the best results, the nonoptimal conditions al-
lowed for a clear differentiation of the catalytic activities almost identical Trx fold. The Pro34His Trx mutant mim-
icking the active site of PDI provides one example. Thisof the cyclic peptides.
By quantitative replacement of GSSG with the pep- mutant was 35 mV less reducing than the wild-type Trx
[22], but although containing the PDI active site, it re-tides in the presence of GSH, i.e., at a GSH/peptide/
protein molar ratio of 20:4:1, the initial rates were twice mained far from possessing the strongly oxidizing char-
acter of PDI. This would lead to the hypothesis that thethose obtained with GSSG/peptide ratios of 1:1. How-
ever, the yields of reactivated enzyme were significantly amino acid sequence of the active site is not alone
sufficient to determine the order of magnitude of thelowered; indeed, with compound 3 as the best catalyst
only 64% active RNase A was recovered after 11 hr, enzyme redox potentials, but additional conformational
elements or even the whole 3D structure are likely todespite the significantly enhanced initial rate of 6.3
pmol/min. play a role as well. Another observation indicating the
Table 2. Kinetic Parameters of Refolding of 24 
M Reduced and Denatured RNase A at pH 7.4 and 30C, in the Presence of Glutathione
and upon Addition of Compounds 1–3
Protein/GSH/GSSG/Peptide Amaxa (%) ka (h1) vib (pmol/min)
1:40:8:- 83  1 0.18  0.01 3.6  0.2
1:40:8:0.8 (1) 89  1 0.19  0.01 4.1  0.2
1:40:8:0.8 (2) 93  2 0.20  0.01 4.5  0.2
1:40:8:0.8 (3) 95  1 0.22  0.01 5.0  0.2
1:20:4:- 64  2 0.07  0.01 1.1  0.2
1:20:2:2 (1) 80  2 0.09  0.01 1.7  0.2
1:20:2:2 (2) 77  2 0.12  0.01 2.2  0.2
1:20:2:2 (3) 84  2 0.14  0.01 2.8  0.2
1:20:-:4 (1) 58  3 0.23  0.03 3.2  0.5
1:20:-:4 (2) 56  1 0.37  0.02 5.0  0.3
1:20:-:4 (3) 66  1 0.40  0.02 6.3  0.3
1:-:4:- 53  2 0.07  0.01 0.9  0.1
1:-:-:4 (1) 75  1 0.14  0.01 2.5  0.2
1:-:-:4 (2) 79  1 0.19  0.01 3.6  0.2
1:-:-:4 (3) 85  2 0.20  0.02 4.1  0.4
a Amax and k are the maximal yield and the first-order rate constant extrapolated from the fitting of the experimental curves with Equation 6.
b Initial rate obtained from the first derivative of Equation 6 for t  0 and converted from %/h to pmol/min.
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Figure 5. Reactivation of Reduced and De-
natured RNase A (24 
M) in Different Redox
Buffers at pH 7.4 and 30C
(A) Forty equivalents of GSH with eight equiv-
alents of GSSG (diamonds) in the presence
of 0.8 equivalents of 1 (squares), 2 (circles),
or 3 (triangles). The data points are the aver-
age of triplicate experiments and are fit to
Equation 6.
(B) Either 20 equivalents of GSH with four
equivalents of GSSG (diamonds) or 20 equiv-
alents of GSH with two equivalents of GSSG
and two equivalents of 1 (squares), 2 (circles),
or 3 (triangles).
(C) Twenty equivalents of GSH with four
equivalents of GSSG (diamonds), 1 (squares),
2 (circles), or 3 (triangles).
(D) Four equivalents of GSSG (diamonds), 1
(squares), 2 (circles), or 3 (triangles).
complexity of the redox system of oxidoreductases is [23], 7.1–7.4 for Trx-Cys32 [40]), a property that has been
attributed to the stabilization of the thiolate group bythat, although the 	 turn conformation adopted by the
linear Trr octapeptide in the oxidized form was practi- the active-site  helix dipole [41]. Moreover, a hydrogen
bond between the N-terminal active-site Cys thiolatecally superimposable to the active site of the native
protein [38], the redox potential of the synthetic frag- and the C-terminal active-site Cys thiol was suggested
to be present in the NMR structure of reduced E. coliment was not comparable to that of the protein [39].
The assumption that introducing an artificial confor- Trx [42], in the crystal structure of human Trx [43] and
E. coli DsbA [44], and in the NMR structure of E. colimational restriction into excised fragments of these en-
zymes might induce different redox properties was fully Grx-3 [45].
Although one of the two Cys residues within the Cys-confirmed in the present study. Indeed, with the excep-
tion of the Trr motif, backbone cyclization conferred Xaa-Yaa-Cys motifs of the cyclic peptides showed sig-
nificantly different ionization properties compared tomore oxidizing activity to the bis(cysteinyl) systems.
Moreover, the redox potential range covered by the cy- those of a normal Cys residue, its nucleophilic character
was still much weaker than that found in the PDI andclic compounds 1–4 was almost three times broader
than that covered by the related linear octapeptides, DsbA enzymes, and a sequence dependency of the pKa
value as observed in the case of mutants of the Dsband this allowed us to markedly distinguish one se-
quence from the others. family [21] was not found in the cyclic active-site frag-
ments. Again, these results suggest that the structuralInterestingly, with a redox potential of130 mV, which
is close to that of the bacterial enzyme DsbA [21], the environment that surrounds the enzyme active site af-
fects the nucleophilicity of the thiol groups.cyclic motif of PDI was the best oxidant among those
examined, just as the PDI enzyme is the strongest oxi- The NMR experiments carried out on the reduced Trx
and PDI peptides at different pH values revealed thatdant within the Trx family. Surprisingly, the E0 value of
the cyclic Trx sequence was almost 120 mV higher than Cys32 was the more acidic one in the Trx peptide, as in
the enzyme, and Cys39 was the more acidic one in thethat of the native protein; however, it should be pointed
out that, with the exception of the PDI-related linear PDI peptide, contrary to the situation in the native en-
zyme. The formation of the thiol anion of Cys39 insteadfragment, all eight linear and cyclic synthetic fragments
were more oxidizing than the natural proteins (Table 1). of Cys36 in the PDI fragment may be partially favored by
the presence of His38, which accordingly showed anThe striking difference between peptide and enzyme
redox potentials would be in agreement with the previ- increase in its pKa value from 6.0 to 6.5, as determined
by NMR pH titration (data not shown).ous hypothesis that the E0 values of the enzymes are the
result of a combination of the amino acid composition of The high tendency of the Trx and PDI peptides to form
mixed disulfides with glutathione can be related to theirthe redox site and the entire protein structure.
Of interest was the finding that in each of the peptide high redox potentials, but also electrostatic interactions
involving the negative net charge of glutathione and thedithiols the pKa value of one SH group was about two
pKa units lower than the other. This reflects what was lysine and/or histidine side chains on the two peptides
[46] can favor the formation of mixed disulfides. In fact,also found in the native enzymes, in which the more
N-terminal Cys residue is extraordinarily nucleophilic mixed disulfides with cysteine lacking a net charge were
formed in relatively smaller amounts.(e.g., pKa of 3.3 for DsbA-Cys30 [21], 4.5 for PDI-Cys36
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Nagel, Du¨ren, Germany) and XTerra MS C8 (5 
m, 3.9  150 mm,In addition to its chaperone activity [1–3], which is still
Waters) columns and a linear gradient from CH3CN/2% H3PO4 (5:95)disputed [47], the main role of PDI relies on both the
to CH3CN/2% H3PO4 (90:10) in 15 min (flow rate, 1.5 ml/min; UVoxidation of cysteines and the isomerization of nonna-
detection at 210 nm). Preparative HPLC was carried out on Abimed
tive disulfide bonds. In glutathione buffer, folding inter- equipment (Langenfeld, Germany) with Nucleosil C18 (5 
m, 100 A˚,
mediates between the reduced proteins and glutathione 21  250 mm, Macherey-Nagel) or C8 (5 
m, 300 A˚, 21  250 mm,
Macherey-Nagel) columns and the following gradients of 0.08% TFArepresent the PDI and Grx substrates that display syner-
in CH3CN (A) and 0.1% TFA in H2O (B) at a flow rate of 10 ml/min:gistic activities on the catalysis of thiol/disulfide ex-
5%–55% (A) over 40 min for the Cys(StBu)-cyclopeptides; 15% (A)change reactions along the oxidative refolding pathway
for 5 min to 50% (A) over 90 min for compound 1; 2% (A) for 4 min[48, 49]. Under optimal GSH/GSSG buffer conditions,
to 50% (A) over 56 min for compound 2; 2% (A) for 4 min to 50%
addition of the PDI enzyme to reduced RNase A en- (A) over 46 min for compound 3; 2% (A) for 15 min to 40% (A) over
hanced the steady-state rate of the in vitro refolding 45 min for compound 4.
ESI-MS spectra were recorded on a Perkin-Elmer SCIEX API 165several times [33]. In comparison, catalytic amounts of
triple quadrupole spectrometer. LC-MS was carried out with athe PDI peptide enhanced the initial rate only moder-
Nucleosil C18 column (5 
m, 100 A˚, 1  250 mm, Macherey-Nagel)ately, nevertheless of significance was the almost quan-
with linear gradients of 0.1% TFA in H2O and 0.08% TFA in CH3CNtitative recovery of refolded RNase A. In the absence of
(flow rate: 30 
l/min; detection at 210 nm). Quantitative amino acid
glutathione buffer, and thus under conditions providing analysis of the acid hydrolysates (6 M HCl  2.5% thioglycolic acid,
the required oxidizing equivalents by the cyclic pep- 110C, 48 hr) was performed on a Biotronik amino acid analyzer
(model LC 6001), in order to confirm the amino acid compositiontides, i.e., at the 4:1 peptide/protein ratio, the peptides
as well as to determine the peptide content. UV measurements wereproved to be much more efficient than GSSG. Under
recorded on a Perkin-Elmer spectrophotometer (model Lambda 19)these conditions, the folding pathway involves a direct
equipped with a thermostated cuvette holder and a Peltier tempera-transfer of the peptide disulfide to the reduced RNase
ture programmer (DBS, Padova, Italy); quarz cuvettes with a light
A via covalent disulfide-bridged intermediates and then path of 1 cm were also used. The pH values were measured on a
an escape of the peptide as a dithiol as a result of Metrohm (Herisau, Switzerland) pH meter (model E 632), freshly
calibrated with pH 7.00, pH 8.00, pH 9.00, and pH 10.00 standardits low Kox value. The dithiol form, in turn, initiates the
solutions from Merck.isomerization process via its nucleophilic attack on non-
native disulfides, from which the peptide finally escapes
Synthesis of the Monocyclic Grx, Trx, PDI,in its reduced form.
and Trr HexapeptidesThe results obtained with the cyclic bis(cysteinyl)pep-
Peptide chain assembly was performed with an automated synthe-tides confirm that, in addition to a highly oxidizing redox
sizer (0.12 mmol scale) or by hand (0.3 mmol scale) on preloaded
potential required for an efficient transfer of oxidizing chlorotrityl resin (0.43–0.54 mmol/gr) from Pepchem (Tu¨bingen, Ger-
equivalents to the protein substrates, a low pKa of one many) by the use of Fmoc amino acids (Alexis, La¨ufelfingen, Switzer-
land) with the following side-chain protecting groups: tBu for Asp,Cys residue in the active site and particularly the chaper-
Thr, and Tyr; Boc for Lys and Trp; Trt for His; and StBu for Cys.one activity of the protein disulfide isomerases PDI [1–3]
Double couplings (2  45 min) were performed in NMP at Fmoc-and DsbC [50] are decisive for the catalytic efficiency
Xaa-OH/HBTU/HOBt/DIEA molar ratios of 4:4:4:8, or 4:4:4:5 forof these foldases. The cyclic hexapeptides and espe-
Cys(StBu) to avoid racemization [52]. For Fmoc cleavage, double
cially the PDI peptide showed interesting redox and treatment with 20% piperidine in NMP (1  13 min) was applied.
acidic properties and, despite the lack of chaperone The side chain-protected linear peptides related to Trx, PDI, and
Trr were cleaved from the resin with 1% TFA in CH2Cl2 (10 x 4 min).activity, provided better protein refolding conditions
The filtrates were analyzed by TLC (CHCl3/MeOH/H2O, 8:3:1) andthan the glutathione redox buffer.
the peptide-containing filtrates were combined and poured into 10%
pyridine in MeOH. The resulting solutions were concentrated to aSignificance
minimum volume, and the peptides were precipitated from ice-cold
water, filtered off, and dried. The Grx-related peptide was cleaved
Since its introduction, the glutathione buffer has been from the resin with TFA/triethylsilane (99:1) in order to simultane-
ously deprotect the Tyr side chain. After being stirred for 1 hr atroutinely used for refolding cystine-containing pro-
room temperature, the mixture was concentrated to a small volume,teins in vitro [51], and in order to bypass the absence
and the product was precipitated from cold ether, isolated by centrif-of molecular chaperones, researchers have generally
ugation, and dried. The crude peptide was then purified by gelapplied aggregation-preventing additives such as
chromatography on Fractogel TSK/HW 40S (Merck AG, Darmstadt,
guanidine hydrochloride or related compounds to this Germany) under MPLC conditions with 2-propanol/n-butanol/0.1 M
process. Recently, the addition of dithiols has been ammonium acetate (pH 5.8) (2:2:7) as eluent (detection at 214 nm).
The linear hexapeptides were characterized by ESI-MS and analyti-shown to offer significant advantages [32]. In this con-
cal HPLC (homogeneity  90%).text, low-mass cyclic bis(cysteinyl)peptides, which
Head-to-tail cyclization was accomplished in freshly distilled DMFcan be readily separated from the refolded proteins,
at 0.8 mM peptide concentration and 0C–5C in the presence ofmay represent a major advance because members of
HOBt/HBTU (1.5 equivalents each) by the addition of DIEA (4 equiva-
this class of dithiol folding adjuvants guarantee effi- lents) portionwise over 2 hr. After completion of the reaction (gener-
cient transfer of oxidizing equivalents to the substrate ally within 3 hr) as monitored by HPLC, the solvent was removed,
and the products were precipitated from AcOEt with n-hexane. Theand retain the required disulfide reshuffling properties.
side chain-protected cyclic peptides were then exposed to TFA/
triisopropylsilane/H2O (92:4:4) for 2 hr at room temperature and suc-Experimental Procedures
cessively concentrated to a small volume. The crude products were
precipitated with cold ether, collected by centrifugation, lyophilizedMaterials and Methods
All amino acid derivatives, resins, reagents, and solvents were of the from tert-butanol/H2O (4:1), and purified by preparative HPLC. The
lyophilized peptides were analytically characterized by ESI-MS andhighest quality commercially available. For peptide characterization,
analytical HPLC was performed on Waters equipment (Eschborn, HPLC (homogeneity  95%).
Final deprotection of the cysteine thiol groups was achieved byGermany) with Nucleosil C8 (5 
m, 100 A˚, 4  125 mm, Macherey-
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reduction at room temperature with excess tributylphosphine (20 Assignment of each HPLC peak was achieved by LC-ESI-MS as
well as by coelution with the authentic samples of Pox and Pred.equivalents) in TFE/H2O (95:5) at 1 mM peptide concentration. After
3 hr, the reaction mixtures were taken to dryness, and the solid Compound 1: tR(min)/[M  H] 22.22/1233.6 (1232.8 calculated
for P-(SG)2), 24.30/928.4 and 25.33/928.4 (927.5 calculated for P-SG),residues were dissolved in a small volume of MeOH and precipitated
with cold ether. The precipitates were collected by centrifugation, 28.14/621.2 (620.2 calculated for Pox), 31.63/623.2 (622.2 calculated
for Pred).washed several times with ether, and lyophilized from tert-butanol/
H2O (4:1). The dry peptides were found to be highly homogeneous Compound 4: tR(min)/[M  H] 22.37/563.2 (562.2 calculated for
Pox), 24.84/1175.4 (1174.8 calculated for the P-(SG)2), 25.97–26.12/at the HPLC ( 95%).
Reduced Grx peptide 1: ESI-MS, 623.2 [M  H]; Mr  622.22 870.4 (869.5 calculated for P-SG), 27.90/565.4 (564.2 calculated for
Pred).(calculated for C27H38N6O7S2).
Reduced Trx peptide 2: ESI-MS, 675.4 [M  H]; Mr  674.27
(calculated for C30H42N8O6S2).
Thiol/Disulfide Exchange Equilibria with Cysteine/CystineReduced PDI peptide 3: ESI-MS, 715.4 [M  H]; Mr  714.27
Equilibration of compounds 1–4 with the cysteine/cystine redox pair(calculated for C31H42N10O6S2).
was performed according to the same procedure as with glutathi-Reduced Trr peptide 4: ESI-MS, 565.2 [M  H]; Mr  564.17
one. Because of the low solubility of cystine, lower peptide concen-(calculated for C20H32N6O9S2).
trations (5–16 
M) were used to maintain the reference redox pair
in large excess over the peptides. The following [cysteine]/[cystine]Synthesis of the Bicyclic Peptides 1–4
molar ratios were used: 1.99, 3.95, 6.90, and 9.95 for compound 1;Oxidation of the monocyclic to the bicyclic peptides 1–4 was per-
2.00, 3.95, 6.90, 8.86, and 9.96 for compound 2; 2.00, 3.95, 6.90,formed in organic solvent with di-tert-butyl azodicarboxylate or in
and 9.96 for compound 3; and 7.00, 9.99, 26.52, and 42.50 for com-aqueous solution with air oxygen. To the peptide solution (0.27 mM
pound 4. The reaction mixtures were equilibrated at 25.0  0.1Cin DMF) di-tert-butyl azodicarboxylate (1 equivalent in DMF) was
for 4 hr, quenched with 1 M H3PO4, and analyzed by HPLC for theiradded portionwise over 20 min. The mixture was stirred for 3 hr at
product distribution. Optimal elution conditions were achieved forroom temperature, then taken to dryness. The solid was dissolved
all four systems with the linear gradients reported above for equili-in a small volume of MeOH and, after the addition of ether, the
bration with glutathione.precipitate was centrifuged and lyophilized from tert-butanol/H2O
Again, characterization of the product distribution was achieved(4:1). This procedure was successful for the preparation of com-
by LC-ESI-MS and coelution with authentic samples of Pox and Pred.pound 1 and more or less successful for compounds 3 and 4, but
The species P-Cys2 and P-Cys of compounds 1 and 4 were presentit failed in the case of compound 2. Alternatively, the peptide solu-
just at a minor extent and could be unambiguously assigned by LC-tions (0.8 mM in 0.1 M ammonium acetate [pH 7]) were gently shaken
MS only for compound 1.under air-oxygen at room temperature and analyzed at time intervals
Compound 1: tR(min)/[M  H] 23.14/861.4 (860.5 calculated forby HPLC. After 5 days the mixtures were acidified with acetic acid
P-Cys2), 24.26/742.2 (741.4 calculated for P-Cys), 28.13/621.4 (620.2and lyophilized. The bicyclic products were purified by preparative
calculated for Pox), 31.68/623.6 (622.2 calculated for Pred).HPLC and lyophilized.
Compound 2: tR(min)/[M  H] 19.49/913.4 (912.6 calculated forGrx peptide 1: ESI-MS, 621.4 [M  H]; Mr  620.21 (calculated
P-Cys2), 23.96/794.4 and 24.92/794.4 (793.4 calculated for P-Cys),for C27H36N6O7S2); HPLC, 98%; amino acid analysis, Gly 0.96 (1)
26.17/673.4 (672.3 calculated for Pox), 30.89/675.4 (674.3 calculatedPro 1.00 (1) Cys 1.88 (2) Val 0.88 (1) Tyr 1.01 (1); peptide content,
for Pred).85.5%.
Compound 3: tR(min)/[M  H] 16.57/953.4 (952.6 calculated forTrx peptide 2: ESI-MS, 673.4 [M  H]; Mr  672.25 (calculated
P-Cys2), 19.10/834.2 and 20.95/834.2 (833.4 calculated for P-Cys),for C30H40N8O6S2); HPLC, 95%; amino acid analysis, Gly 1.00 (1)
22.98/713.4 (712.3 calculated for Pox), 24.20/715.4 (714.3 calculatedPro 1.00 (1) Cys 1.90 (2) Lys 0.91 (1) Trp 1.03 (1); peptide content,
for Pred).76.7%.
Compound 4: tR(min)/[M  H] 21.95/563.2 (562.2 calculated forPDI peptide 3: ESI-MS, 713.4 [M  H]; Mr  712.26 (calculated
Pox), 27.98/565.2 (564.2 calculated for Pred). Two other peaks at 23.50for C31H40N10O6S2); HPLC, 98%; amino acid analysis, Gly 1.00 (1)
and 25.75 min could not be unambiguously assigned to the speciesCys 1.81 (2) Lys 0.96 (1) His 0.98 (1) Trp 1.00 (1); peptide content,
P-Cys2 and P-Cys by LC-MS. However, in analogy to the elution68.0%.
pattern of the corresponding glutathionylated derivatives, P-Cys2Trr peptide 4: ESI-MS, 563.2 [M  H]; Mr  562.15 (calculated
was assigned to the tR(min) of 23.50 and, consequently, P-Cys tofor C20H30N6O9S2); HPLC, 95%.
25.75.
Thiol/Disulfide Exchange Equilibria with GSH/GSSG
For equilibration with GSH/GSSG, compounds 1–4 were dissolved
Redox Potentials of the Cyclic Peptides 1–4in argon-flushed phosphate buffer (0.1 M, pH 7.0) containing 0.1 M
Despite the multiple equilibria that are established in the thiol/disul-NaCl and 1 mM EDTA. GSH and GSSG were separately dissolved
fide exchange reactions [27], according to the “principle of detailedin phosphate buffer, and the pH of both solutions was adjusted to
balancing” [53] each step can be considered as a separate one and7.0 with 1 M NaOH. In typical equilibration reactions the bicyclic
treated as a two-state model. Assuming that in the HPLC of thepeptides (0.20–0.27 mM) were incubated with 80- up to 200-fold
equilibrated mixtures all species were quantitatively eluted and ex-excess glutathione at different [GSH]/[GSSG] molar ratios (0.31,
hibited identical extinction coefficients at 210 nm, we correlated the0.54, 0.80, 1.00, 1.07, 1.79, and 2.10 for compound 1; 0.38, 0.80,
concentration of each component at equilibrium to the area of the0.88, 1.07, and 2.14 for compound 2; 0.30 and 1.05 for compound
corresponding HPLC peak and used it to obtain the equilibrium3; 0.50, 1.00, 1.50, 2.00, and 3.00 for compound 4). The reaction
constants Keq relative to each redox reaction. The Keq values weremixtures were kept at 25.0 0.1C, and equilibration was monitored
estimated as previously described by Siedler and coworkers [27]by HPLC on aliquots over 3 hr; generally, full equilibration was
and were found to correlate well to each other, thus confirming thereached after 1 hr. The aliquots were immediately quenched with 1
validity of the model. The two approaches applied for the determina-M H3PO4 to pH 2 and analyzed by HPLC with linear gradients of
tion of Keq are reported more in the details of the calculation of Kox,either CH3CN/2% H3PO4, 90:10 (A) and CH3CN/2% H3PO4, 5:95 (B),
which describes the equilibrium between Pred and Pox and is requiredor CH3CN/ 2% H3PO4, 1:99 (B) for compound 4 (compound 1, from
to estimate the redox potential.0 to 25% [A] over 20 min and to 35% [A] over 35 min; compound
In the first method, the [GSH]2 /[GSSG] or [cysteine]2 /[cystine]2, from 0 to 25% [A] over 20 min and to 50% [A] over 35 min;
value used for each experiment and the corresponding [Pox]/[Pred]compound 3, from 0 to 50% [A] over 40 min; compound 4, from 0
ratio estimated from the HPLC were introduced into Equation 1:to 20% [A] over 30 min and to 50% [A] over 30 min). Optimal HPLC
conditions for baseline separation of all theoretically expected com-
ponents were obtained for the cyclopeptides 1 and 4, whereas in Kox 
[Pox] [GSH]2
[Pred] [GSSG]
(1)
the case of peptides 2 and 3 the Pox species could not be detected.
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The Kox values that had been derived from multiple (four to seven) hydrochloride and 62 mM DTT. The reduced, denatured enzyme was
chromatographically separated from salt and DTT by gel filtration onexperiments carried out with each peptide were then averaged.
In the second method, the Kox values were estimated from a rect- Sephadex G-25 (Pharmacia) with 0.01 M HCl as eluent (UV detection
at 275 nm). Fractions corresponding to the central part of the elutionangular hyperbolic fitting via Equation 2:
peak were collected, and the protein concentration was determined
spectrophotometrically [57]. The free thiol concentration was deter-[Pred]
[Pox]  [Pred]

[GSH]2/[GSSG]
Kox  [GSH]2/[GSSG]
(2)
mined by UV measurements with (2,2-dithio)dipyridine [58]. The
reduced protein solution was used immediately or stored under
The Kox values extrapolated from Equation 2 were found to be in argon at 20C overnight.
agreement with those calculated from Equation 1.
Refolding experiments were performed in triplicate at 30.0 0.1C
Finally, the E0 values were obtained from the Nernst Equation: in argon-flushed Tris·HCl buffer (0.1 M, pH 7.4) containing 1.2 mM
EDTA. Stock solutions of compounds 1–3, GSH, and GSSG wereE0  E0 (GSH/GSSG)  0.03 log Kox (3)
prepared by weight and controlled by UV spectroscopy at 248 nm
The redox potentials referring to GSH/GSSG were calculated with for GSSG [59], at 275 and 280 nm for the Tyr- and Trp-containing
the E0 (GSH/GSSG) value of 240 mV [30]. Accordingly, the E0 (cysteine/cystine) peptides, respectively, and by the Grassetti test for GSH [58]. The
value of 245 mV relative to the E0 (GSH/GSSG) value of 262 mV [31] following refolding mixtures were used: GSH/GSSG/protein (40:8:1
was adjusted to 223 mV to calculate the redox potentials referring or 20:4:1), GSH/GSSG/peptide/protein (40:8:0.8:1 or 20:2:2:1), GSH/
to cysteine/cystine. peptide/protein (20:4:1), and peptide/protein (4:1). The assays were
initiated by addition of the reduced and denatured RNase A to the
Titration of the Thiol Groups of the Reduced redox buffers to a final protein concentration of 24 
M. At time
Cyclic Peptides 1–4 intervals, aliquots (60 
l) of the refolding mixtures were taken and
The dithiol peptides were titrated spectrophotometrically at 238 nm added to 800 
l of 465 
M cCMP in MOPS buffer (0.1 M, pH 7), and
[54, 55]. For this purpose solutions of the bicyclic peptides (300 
l, substrate hydrolysis was monitored at 284 nm against a reference
0.38–0.55 
mol) in argon-flushed phosphate buffer (0.1 M, pH 7.0) substrate solution [60] over 3 min at 25C. The concentration of the
were treated with tris-(2-carboxyethyl)phosphine hydrochloride, refolded enzyme was extrapolated from the slope of the approxi-
TCEP (31.2 
l of a 50 mM solution in phosphate buffer, 1.56 
mol). mately linear initial UV traces with a calibration curve derived from
After 1 hr at room temperature, an aliquot was analyzed by HPLC known concentrations of native RNase A [61]. Enzyme reactivation
and ESI-MS to confirm total reduction of the disulfide bond. Samples (average of triplicate experiments) was plotted against time, and
(30 
l) of these solutions were diluted with phosphate buffer (1030 the experimental curves were fit with Equation 6 to obtain the extrap-

l) to a final concentration of 32–47 
M and titrated with 1.7 M olated maximal yield of the reactivation process (Amax) and the first-
H3PO4 and 2 M NaOH directly in the cuvette (the dilution factor on the order rate constant (k ).
peptide concentration was neglected because the overall volume
% RNase A activity  Amax (1  ekt) (6)change was 5%). The absorbance at 238 nm was measured
against phosphate buffer as the blank. Titration of GSSG, reduced
Acknowledgmentswith TCEP under identical conditions as the peptides, was also
performed to assess the confidence of the protocol. All UV measure-
The authors gratefully acknowledge the skillful technical assistancements were recorded at 25C. To take into account the UV contribu-
of Mrs. E. Weyher in the ESI-MS analyses. The study was supportedtion of the Tyr and Trp residues at 238 nm, we pH titrated solutions
by a Marie Curie Fellowship to C.C.of these amino acids at the same molar concentration as that used
for the cyclic peptides.
After subtraction of the absorbance due to the aromatic residues, Received: January 15, 2002
when present, the data points relative to the monocyclic Trx, PDI, Revised: April 17, 2002
and Trr peptides were fit to a double titration model (equation 4) Accepted: April 17, 2002
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